CIK: 1605767 - Address: C/O Kala Bio, Inc., 1167 Massachusetts Avenue, Arlington, MA 02476
14 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11175-1570017
S%wins00100025

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/27/24 20:00
6/26/24
KALAKala Bio, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS-224.750-5-583D
6/3/24 20:00
5/31/24
KALAKala Bio, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS-136.090-2-288D
1/5/24 16:03
1/4/24
KALAKala Bio, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS.d-96.740-1-1000D
1/6/23 20:00
1/4/23
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS-228.5400015D
10/28/22 16:15
10/26/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS-16.5100-92D
6/29/22 20:10
6/27/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS-10.37000-3-3116D
1/5/22 20:00
1/4/22
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOSEE REMAS.d-41.300-3-3119D
10/28/21 20:03
10/26/21
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOCOOS-231.800-13-9122D
6/29/21 17:25
6/28/21
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOCOOS-175.770-3-990D
10/28/20 20:36
6/5/20
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOCOOP.m07.88000110M
3/17/20 17:46
3/16/20
KALAKala Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsBazemore ToddMAOCOOP585.75010New10D
8/19/15 16:18
8/18/15
DYAXDyax CorpDEHealthBiolabCommercial Physical & BiologiBazemore ToddMAOEVP,ChieM.d946.802214New14D46913652-13-10-4-34-5-6748
8/6/15 16:35
8/4/15
DYAXDyax CorpDEHealthBiolabCommercial Physical & BiologiBazemore ToddMAOEVP,ChieM.dm2926.8023430D46814860-9-11-14-5-575-157
8/6/15 16:35
8/4/15
DYAXDyax CorpDEHealthBiolabCommercial Physical & BiologiBazemore ToddMAOEVP,ChieS.dm-1,01623.6223-43-1000D46814860-9-11-14-5-575-157

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact